259 related articles for article (PubMed ID: 8821699)
21. Argyrophilic nucleolar organizer region (AgNOR) area per nucleus as a prognostic factor in breast cancer.
Nakayama K; Abe R
J Surg Oncol; 1995 Nov; 60(3):160-7. PubMed ID: 7475065
[TBL] [Abstract][Full Text] [Related]
22. AgNOR/P53 expression compared with different grades in bladder carcinoma.
Karakök M; Aydin A; Bakir K; Uçak R; Korkmaz C
Int Urol Nephrol; 2001; 33(2):353-5. PubMed ID: 12092655
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.
Bozlu M; Orhan D; Baltaci S; Yaman O; Elhan AH; Tulunay O; Müftüoğlu YZ
Int Urol Nephrol; 2002; 33(1):59-66. PubMed ID: 12090340
[TBL] [Abstract][Full Text] [Related]
24. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumors and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa.
Johnson GC; Miller MA; Ramos-Vara JA
J Vet Diagn Invest; 1995 Jan; 7(1):127-36. PubMed ID: 7779947
[TBL] [Abstract][Full Text] [Related]
25. AgNOR counts and histological grade in stage pTa bladder tumours: reproducibility and relation to recurrence pattern.
Hansen AB; Bjerregaard B; Ovesen H; Horn T
Histopathology; 1992 Mar; 20(3):257-62. PubMed ID: 1563712
[TBL] [Abstract][Full Text] [Related]
26. Cell kinetics analysis in stage I endometrial carcinoma as determined by image cytometry and immunohistochemistry. Correlation with clinicopathologic characteristics.
Miliaras D; Papaemmanuil S
Anal Quant Cytol Histol; 2004 Feb; 26(1):7-14. PubMed ID: 15032075
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
[TBL] [Abstract][Full Text] [Related]
28. Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder.
Mansour P; Crocker J; Newman J
Arch Pathol Lab Med; 1990 Dec; 114(12):1261. PubMed ID: 1701296
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of nucleolar organizer regions in human bladder cancers by light- and electron-microscopic morphometry.
Shimazui T; Uchiyama Y; Uchida K; Hattori K; Takahashi A; Akaza H; Koiso K
Eur Urol; 1998; 34(5):441-7. PubMed ID: 9803008
[TBL] [Abstract][Full Text] [Related]
30. Nuclear DNA content and nucleolar organizer regions in colorectal cancer.
Adachi Y; Kido A; Mori M; Matsushima T; Shimono R; Inoue T; Sugimachi K
J Surg Oncol; 1995 Jul; 59(3):177-80. PubMed ID: 7609524
[TBL] [Abstract][Full Text] [Related]
31. Image analysis of Ag-NOR proteins in transitional cell bladder cancer.
Lipponen P
J Pathol; 1993 Dec; 171(4):279-83. PubMed ID: 8158457
[TBL] [Abstract][Full Text] [Related]
32. [Nucleolar organizer region in bladder cancer. Relationship with histologic grade, stage, and prognosis].
Rivera P; Roa I
Actas Urol Esp; 1994 Mar; 18(3):204-6. PubMed ID: 8036947
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma.
Aubele M; Auer G; Jütting U; Falkmer U; Gais P
Anal Quant Cytol Histol; 1994 Jun; 16(3):211-8. PubMed ID: 7522453
[TBL] [Abstract][Full Text] [Related]
34. Silver-binding argyrophilic nucleolar organizer regions (AgNOR) in gall-bladder cancer: correlations with malignant grading and prognosis.
Suzuki T; Takano Y; Kida Y; Okudaira M
Acta Pathol Jpn; 1993; 43(1-2):36-43. PubMed ID: 8465655
[TBL] [Abstract][Full Text] [Related]
35. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
Pich A; Chiarle R; Chiusa L; Palestro G
Cancer; 1994 Sep; 74(5):1568-74. PubMed ID: 7520349
[TBL] [Abstract][Full Text] [Related]
36. Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value.
Zambelli S; Zanin A; Gaglio A; Zai G; Bosco E; Andrion A; Magnani C
Arch Ital Urol Androl; 1993 Dec; 65(6):665-70. PubMed ID: 8312949
[TBL] [Abstract][Full Text] [Related]
37. Nucleolar organizer regions in bladder cancer: application to urinary cytology.
Masuda M; Nagamoto A; Hirokawa M; Takano Y; Shuin T
Urology; 1994 Aug; 44(2):194-8. PubMed ID: 8048194
[TBL] [Abstract][Full Text] [Related]
38. AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor.
Tomobe M; Shimazui T; Uchida K; Akaza H
Anal Cell Pathol; 2001; 22(4):193-9. PubMed ID: 11564895
[TBL] [Abstract][Full Text] [Related]
39. Nucleolar organizer regions in meningiomas. Correlation with histopathologic malignancy grading, DNA cytometry and clinical outcome.
Plate KH; Ruschoff J; Mennel HD
Anal Quant Cytol Histol; 1990 Dec; 12(6):429-38. PubMed ID: 2078265
[TBL] [Abstract][Full Text] [Related]
40. [Significance of AgNOR analysis of urothelial carcinomas].
Helpap B; Loesevitz L
Verh Dtsch Ges Pathol; 1993; 77():222-5. PubMed ID: 7511285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
